Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

Phaeochromocytoma and paraganglioma (PPGL) are chromaffin cell tumours that require
timely diagnosis because of their potentially serious cardiovascular and sometimes life …

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that
arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic …

Pheochromocytomas and paragangliomas (PCC/PGLs) are rare, mostly catecholamine-
producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal …

Pheochromocytoma and paraganglioma (PPGL) require prompt consideration and efficient
diagnosis and treatment to minimize associated morbidity and mortality. Once considered …

This article aims to review current concepts in diagnosing and managing
pheochromocytoma and paraganglioma (PPGL). Personalized genetic testing is vital, as 40 …

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors with
heterogeneous clinical presentations and potential lethal outcomes. The diagnosis is based …

The risk factors for severe COVID-19 are diverse, yet closely resemble the clinical
manifestations of catecholamine excess states (eg, hypertension, cardiovascular disease …

Pheochromocytomas and sympathetic paraganglioma (PPGL) are rare chromaffin cell
tumors originating in the adrenal medulla and sympathetic paraganglia, respectively, which …

Objectives Plasma free metanephrines are commonly used for diagnosis of
pheochromocytoma and paraganglioma (PPGLs), but can also provide other information …